Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Quarterly turnover from beta agonists in Denmark 2018

This statistic shows the quarterly turnover from beta agonists for systematic use, to treat respiratory and pulmonary disease, in Denmark in 2018. The highest turnover during 2018 was in the first quarter, which amounted to 231.1 million Danish kroner.

Turnover from beta agonists in Denmark from 1st quarter to 4th quarter 2018

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until November 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Denmark

Survey time period

Q1 to Q4 2018

Special properties

refers to beta agonists for systematic use

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Respiratory disease in Sweden "

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.